CAPR

MKT CAP:$2B

Capricor Therapeutics, Inc.

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$35.34+$7.03 (+24.83%)

Apr 21, 2026

Company Details

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate...

CEO

Linda Marbán

IPO Date

Feb 13, 2007

Website

www.capricor.com

Key Metrics TTM

Revenue

$13M

-50.7% YoY

Net Income

-$70M

EPS (Diluted)

-$1.64

Free Cash Flow

-$56M

Revenue / Share

$0.29

Gross Margin

-402.7%

Operating Margin

-548.2%

Net Margin

-522.5%

FCF Margin

-421.0%

P/S

118.3x

P/E

—

Earnings Reports

Q3 2025

May 12, 2026

PENDING

Q2 2025

Aug 11, 2025

$0-100.0%EPS -$0.57

Q1 2025

May 14, 2025

$0-100.0%EPS -$0.53

FY 2024

Mar 26, 2025

$22M-11.5%EPS -$1.15

Q4 2024

Mar 26, 2025

$11M-7.9%EPS -$0.16

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$0	$0	-$4M
Q4 21	$0	$0	-$6M
Q1 22	$0	$0	-$8M
Q2 22	$0	$0	-$7M
Q3 22	$2M	$2M	-$6M
Q4 22	$959.9K	$959.9K	-$8M
Q1 23	$3M	$3M	-$8M
Q2 23	$4M	$4M	-$8M
Q3 23	$6M	$6M	-$7M
Q4 23	$12M	$2M	-$1M
Q1 24	$5M	-$6M	-$10M
Q2 24	$4M	-$9M	-$12M
Q3 24	$2M	-$10M	-$13M
Q4 24	$11M	-$3M	-$8M
Q1 25	$0	-$19M	-$25M
Q2 25	$0	-$22M	-$28M

Valuation

Quarter	P/S	P/E
Q3 21	341.8x	—
Q4 21	315.3x	—
Q1 22	458.1x	—
Q2 22	—	—
Q3 22	96.4x	—
Q4 22	37.4x	—
Q1 23	19.3x	—
Q2 23	12.8x	—
Q3 23	5.7x	—
Q4 23	6.7x	—
Q1 24	8.3x	—
Q2 24	5.9x	—
Q3 24	23.1x	—
Q4 24	21.8x	—
Q1 25	25.0x	—
Q2 25	33.9x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 21	-$3M	-$4M
Q4 21	-$6M	-$6M
Q1 22	$24M	$23M
Q2 22	-$7M	-$7M
Q3 22	-$6M	-$7M
Q4 22	-$7M	-$8M
Q1 23	$4M	$4M
Q2 23	-$9M	-$10M
Q3 23	-$9M	-$9M
Q4 23	-$12M	-$12M
Q1 24	-$1M	-$2M
Q2 24	-$12M	-$12M
Q3 24	-$12M	-$12M
Q4 24	-$15M	-$16M
Q1 25	-$6M	-$8M
Q2 25	-$20M	-$22M

Capital Expenditures

Quarter	CapEx
Q3 21	$468.2K
Q4 21	$368.7K
Q1 22	$625.4K
Q2 22	$412.6K
Q3 22	$1M
Q4 22	$1M
Q1 23	$453.1K
Q2 23	$233.4K
Q3 23	$631.8K
Q4 23	$729.2K
Q1 24	$664.3K
Q2 24	$80.9K
Q3 24	$59.0K
Q4 24	$734.7K
Q1 25	$1M
Q2 25	$1M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	-100.0%	+9.8%
Q4 21	-100.0%	+50.5%
Q1 22	-100.0%	+50.6%
Q2 22	-100.0%	+38.5%
Q3 22	—	+87.0%
Q4 22	—	+41.5%
Q1 23	—	+42.6%
Q2 23	—	+59.3%
Q3 23	+288.7%	+61.7%
Q4 23	+1159.3%	+48.1%
Q1 24	+64.3%	+35.8%
Q2 24	+1.4%	+33.4%
Q3 24	-63.4%	+17.0%
Q4 24	-7.9%	+40.8%
Q1 25	-100.0%	+64.7%
Q2 25	-100.0%	+78.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 21	$720.3K	—
Q4 21	$780.1K	—
Q1 22	$0	—
Q2 22	$0	—
Q3 22	$1M	68.3%
Q4 22	$1M	119.6%
Q1 23	$0	0.0%
Q2 23	$2M	41.3%
Q3 23	$2M	27.8%
Q4 23	$2M	15.4%
Q1 24	$3M	66.5%
Q2 24	$2M	54.2%
Q3 24	$2M	90.7%
Q4 24	$2M	20.6%
Q1 25	$6M	—
Q2 25	$4M	—

OpEx Breakdown

Quarter	R&D	G&A
Q3 21	$3M	$2M
Q4 21	$4M	$2M
Q1 22	$5M	$3M
Q2 22	$5M	$2M
Q3 22	$6M	$3M
Q4 22	$6M	$3M
Q1 23	$8M	$3M
Q2 23	$9M	$3M
Q3 23	$10M	$3M
Q4 23	$10M	$3M
Q1 24	$11M	$4M
Q2 24	$13M	$3M
Q3 24	$12M	$3M
Q4 24	$15M	$4M
Q1 25	$19M	$6M
Q2 25	$22M	$6M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$58M	$0	$58M
Q2 22	$16M	$35M	$51M
Q3 22	$8M	$38M	$47M
Q4 22	$10M	$32M	$41M
Q1 23	$11M	$35M	$45M
Q2 23	$10M	$28M	$38M
Q3 23	$9M	$20M	$29M
Q4 23	$15M	$25M	$39M
Q1 24	$6M	$34M	$40M
Q2 24	$11M	$19M	$29M
Q3 24	$68M	$17M	$85M
Q4 24	$11M	$140M	$152M
Q1 25	$29M	$116M	$145M
Q2 25	$23M	$100M	$123M
Q3 25	$20M	$79M	$99M
Q4 25	$288M	$30M	$318M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	23M	+1.0%	+16.6%
Q4 21	24M	+4.6%	+18.5%
Q1 22	24M	+0.5%	+9.2%
Q2 22	24M	+0.2%	+6.4%
Q3 22	24M	+0.4%	+5.8%
Q4 22	25M	+3.0%	+4.2%
Q1 23	25M	+0.3%	+4.0%
Q2 23	25M	+0.3%	+4.2%
Q3 23	26M	+1.9%	+5.7%
Q4 23	27M	+3.7%	+6.4%
Q1 24	31M	+17.1%	+24.2%
Q2 24	32M	+1.6%	+25.7%
Q3 24	33M	+3.9%	+28.2%
Q4 24	35M	+6.4%	+31.5%
Q1 25	46M	+29.6%	+45.5%
Q2 25	46M	+0.2%	+43.5%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	$0	26
Q4 21	$0	48
Q1 22	$0	48
Q2 22	$0	48
Q3 22	$33.2K	48
Q4 22	$13.0K	74
Q1 23	$40.4K	74
Q2 23	$52.9K	74
Q3 23	$83.6K	74
Q4 23	$118.5K	102
Q1 24	$48.1K	102
Q2 24	$38.9K	102
Q3 24	$22.2K	102
Q4 24	$69.6K	160
Q1 25	$0	160
Q2 25	$0	160

Revenue / Employee